セルスペクト株式会社

Morioka, JP · 3 known investors

Cellspect develops next-generation clinical diagnostic reagents and in-vitro diagnostic products based on deep-tech, covering diagnostic technologies from biomarker discovery to treatment monitoring. It offers open-innovation partnerships with pharmaceutical companies and medical institutions, including point-of-testing and precision oncology products, based in Iwate, Japan.

BiotechDeep TechDigital HealthHealthtechMedical Devices